Follow

Submissions from 2015

Link

Methods for reducing sepsis mortality in emergency departments and inpatient units, M. E. Doerfler, J. D'Angelo, D. Jacobsen, M. P. Jarrett, A. I. Kabcenell, K. D. Masick, D. Parmentier, K. L. Nelson, and L. Stier

Link

Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis, R. Furie, K. Toder, and E. Zapantis

Submissions from 2014

PDF

Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study, A. Goldberg, T. Geppert, E. Schiopu, T. Frech, V. Hsu, R. W. Simms, S. L. Peng, Y. H. Yao, N. Elgeioushi, S. Yoo, and +2 additional authors

PDF

A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort, R. L. Gross, J. S. Schwartzman-Morris, M. Krathen, G. Reed, H. Chang, K. C. Saunders, M. C. Fisher, J. D. Greenberg, C. Putterman, A. Broder, and +3 additional authors

Development of Pulmonary Hypertension in a High-risk Population with Systemic Sclerosis in the Pulmonary Hypertension Assessment and RAecognition of Outcomes in Scleroderma (PHAROS) Cohort Study, V M. Hsu, L Chung, L K. Hummers, F Wigley, R Simms, M Bolster, R Silver, A Fischer, A Z. Goldberg, V D. Steen, and +13 additional authors